Alterations in Angiotensin Converting Enzyme During Rodent Aortic Aneurysm Formation

Journal of Surgical Research

Volumn 132, Issue 1, 2006, Pages 69-73

  Eagleton, Matthew J ^a   Cho, Brenda ^a   Lynch, Erin ^a   Roelofs, Karen ^a   Woodrum, Derek ^a   Stanley, James C ^a   Upchurch Jr , Gilbert R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

abdominal aortic aneurysm; angiotensin converting enzyme; angiotensin II; angiotensin II receptor; elastase

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; ELASTASE; MESSENGER RNA; RNA; SODIUM CHLORIDE;

ANALYSIS OF VARIANCE; ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; AORTA WALL; ARTICLE; BLOOD VESSEL DIAMETER; COMPARATIVE STUDY; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PERFUSION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RODENT; STAINING; STATISTICAL ANALYSIS; STUDENT T TEST; WESTERN BLOTTING;

ANIMALS; AORTA; AORTIC ANEURYSM; DISEASE MODELS, ANIMAL; KINETICS; MALE; PANCREATIC ELASTASE; PEPTIDYL-DIPEPTIDASE A; PERFUSION; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER;

EID: 33645970195     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2005.09.023     Document Type: Article

References (19)

1. Daugherty A., Manning M., and Cassis L. Angiotensin II promoted atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J. Clin. Invest. 105 (2000) 1605
2. Laio S., Miralles M., Kelley B.J., et al. Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors. J. Vasc. Surg. 33 (2001) 1057
3. Nishimoto M., Takai S., Fukumoto H., et al. Increased angiotensin II formation in aneurysmal aorta. Life Sci. 71 (2002) 2195
4. Pyo R., Lee J., Shipley J., et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J. Clin. Invest. 105 (2000) 1641
5. Anidjar S., Salzman J., Gentric D., et al. Elastase-induced experimental aneurysms in rats. Circulation 82 (1990) 973
6. Ailawadi G., Eliason J., Roelofs K., et al. Gender differences in experimental aortic aneurysm formation. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 2116
7. Sinha I., Hannawa K., Eliason J., et al. Early MT-1 MMP expression following elastase exposure is associated with increased exposure is associated with increased cleaved MMP-2 activity in experimental rodent aortic aneurysms. Surgery 136 (2004) 176
8. Arakawa K., and Maruta H. Ability of kallikrein to generate angiotensin II-like pressor substance and a proposed 'kinin-tensin enzyme system.'. Nature 288 (1980) 705
9. Urata H., Kinoshita A., Misono K., et al. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J. Biol. Chem. 265 (1990) 22348
10. Ihara M., Urata H., Kinoshita A., et al. Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta. Hypertension 33 (1999) 1399
11. Tsunemi K., Takai S., Nishimoto M., et al. Possible roles of angiotensin II-forming enzymes, angiotensin converting enzyme and chymase-like enzyme, in the human aneurysmal aorta. Hyptertens. Res. 25 (2002) 817
12. Nagashima H., Uto K., Sakomura Y., et al. An angiotensin-converting enzyme inhibitor, not an angiotensin II type-1 receptor blocker, prevents B-aminopropionitrile monofumarate-induced aortic dissection in rats. J. Vasc. Surg. 36 (2002) 818
13. Aberg G., and Ferrer P. Effects of captopril on atherosclerosis in cynomolgus monkeys. J. Cardiovasc. Pharmacol. 15 (1990) S65
14. Chobanian A., Haudenschild C., Nickerson C., et al. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension 15 (1990) 327
15. Vanhoutte P., Boulanger C., Illiano S., et al. Endothelium-dependent effects of converting-enzyme inhibitors. J. Cardiovasc. Pharmacol. 22 (1993) S10
16. Mancini G., Henry G., Macaya C., et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing Endothelial Dysfunction) Study. Circulation 94 (1996) 258
17. Yusof S., Sleight P., Pogue J., et al. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N. Engl. J. Med. 342 (2000) 145
18. Schieffer B., Bunte C., Witte J., et al. Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease. J. Am. Coll. Cardiol. 44 (2004) 362
19. Turner A., and Hooper N. The angiotensin-converting enzyme gene family. Genomics and pharmacology. Trends Pharmacol. Sci. 23 (2002) 177